Sarcoma Metabolomics: Current Horizons and Future Perspectives

被引：10

作者：

Esperanca-Martins, Miguel ^{[1
,2
,3
]}

Fernandes, Isabel ^{[1
,3
,4
]}

Soares do Brito, Joaquim ^{[4
,5
]}

Macedo, Daniela ^{[6
]}

Vasques, Hugo ^{[4
,7
]}

Serafim, Teresa ^{[2
]}

Costa, Luis ^{[1
,3
,4
]}

Dias, Sergio ^{[2
,4
]}

机构：

[1] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Med Oncol Dept, P-1649028 Lisbon, Portugal

[2] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Vasc Biol & Canc Microenvironm Lab, P-1649028 Lisbon, Portugal

[3] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Translat Oncobiol Lab, P-1649028 Lisbon, Portugal

[4] Univ Lisbon, Fac Med, P-1649028 Lisbon, Portugal

[5] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Orthoped & Traumatol Dept, P-1649028 Lisbon, Portugal

[6] Hosp Lusiadas Lisboa, Med Oncol Dept, P-1500458 Lisbon, Portugal

[7] Inst Portugues Oncol Francisco Gentil, Gen Surg Dept, P-1099023 Lisbon, Portugal

来源：

CELLS | 2021年 / 10卷 / 06期

关键词：

sarcoma; soft tissue sarcoma; bone sarcoma; gastrointestinal stromal tumor; metabolomics; metabolism; SOFT-TISSUE SARCOMA; IN-VITRO; CELL-LINES; CANCER; OSTEOSARCOMA; TUMORS; METABOLISM; INHIBITORS; HALLMARKS; PATHWAY;

D O I：

10.3390/cells10061432

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The vast array of metabolic adaptations that cancer cells are capable of assuming, not only support their biosynthetic activity, but also fulfill their bioenergetic demands and keep their intracellular reduction-oxidation (redox) balance. Spotlight has recently been placed on the energy metabolism reprogramming strategies employed by cancer cells to proliferate. Knowledge regarding soft tissue and bone sarcomas metabolome is relatively sparse. Further characterization of sarcoma metabolic landscape may pave the way for diagnostic refinement and new therapeutic target identification, with benefit to sarcoma patients. This review covers the state-of-the-art knowledge on cancer metabolomics and explores in detail the most recent evidence on soft tissue and bone sarcoma metabolomics.

引用

页数：23

共 50 条

[1] Synovial Sarcoma: Current Concepts and Future Perspectives
Stacchiotti, Silvia
Van Tine, Brian Andrew
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (02) : 180 - +
[2] Immunotherapy in Sarcoma: Future Horizons
Burgess, Melissa
Gorantla, Vikram
Weiss, Kurt
Tawbi, Hussein
CURRENT ONCOLOGY REPORTS, 2015, 17 (11)
[3] Immunotherapy in Sarcoma: Future Horizons
Melissa Burgess
Vikram Gorantla
Kurt Weiss
Hussein Tawbi
Current Oncology Reports, 2015, 17
[4] Current perspectives of nuclear magnetic resonance metabolomics in melanoma
Liu, Zhenhe
Zhai, Guanzhong
Liu, Litao
Zhang, Jinguo
MINERVA BIOTECNOLOGICA, 2018, 30 (02) : 63 - 68
[5] Metabolomics in cancer biomarker discovery: Current trends and future perspectives
Armitage, Emily G.
Barbas, Coral
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 87 : 1 - 11
[6] Probiotics: current landscape and future horizons
Day, Richard L. J.
Harper, Ashton J.
Woods, Rachel M.
Davies, Owen G.
Heaney, Liam M.
FUTURE SCIENCE OA, 2019, 5 (04):
[7] Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
Gordon, Erlinda M.
Sankhala, K. Kumar
Chawla, Neal
Chawla, Sant P.
ADVANCES IN THERAPY, 2016, 33 (07) : 1055 - 1071
[8] Olaratumab in soft tissue sarcoma - Current status and future perspectives
Antoniou, Georgios
Lee, Alexander T. J.
Huang, Paul H.
Jones, Robin L.
EUROPEAN JOURNAL OF CANCER, 2018, 92 : 33 - 39
[9] Tazemetostat for advanced epithelioid sarcoma: current status and future perspectives
Simeone, Noemi
Frezza, Anna Maria
Zaffaroni, Nadia
Stacchiotti, Silvia
FUTURE ONCOLOGY, 2021, 17 (10) : 1253 - 1263
[10] Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting
Bonomo, Roberta
Cavaletti, Guido
Skene, Debra J.
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2020, 20 (07) : 725 - 738

← 1 2 3 4 5 →